alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JAN-01-1997
<CASH>                                              49
<SECURITIES>                                         0
<RECEIVABLES>                                      391
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   440
<PP&E>                                          30,934
<DEPRECIATION>                                 (1,241)
<TOTAL-ASSETS>                                  31,996
<CURRENT-LIABILITIES>                            2,124
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         7,615
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    31,996
<SALES>                                              0
<TOTAL-REVENUES>                                 3,837
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,487
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,375
<INCOME-PRETAX>                                (1,025)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,025)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,025)
<EPS-PRIMARY>                                   (0.68)
<EPS-DILUTED>                                   (0.68)


</TABLE>
#### § 835.1201 Sealed radioactive source control.

Sealed radioactive sources shall be used, handled, and stored in a manner commensurate with the hazards associated with operations involving the sources.
STATE OF TENNESSEE DEPARTMENT OF ENVIRONMENT AND CONSERVATION Air Pollution Control Division 9th Floor, L & C Annex, 401 Church Street,Nashville, TN 37243 July 30,2010 A. Stanley Meiburg Acting Regional Administrator US EPA, Region 

### IV Atlanta Federal Center, 12~ Floor 61 Forsyth Street, SW Atlanta, GA 30303 

### RE: GreenhouseGas Tailoring Rule Dear Mr. Meiburg: The State of TennesseeDepartment of Environment and Conservation 

### ,Air Pollution Control Division has initiatedrulemaking to add the definition of "subject to regulation" to both our PSD [1200-03-09- .01(4)] and Title V 11200-03-09-.02(1 I)] regulations. This revision is only necessary to insurethe higher applicability thresholds specifiedinthe June 3,2010 edition of the Federal Register will be in effect. The existing regulations allow the Division to require PSD and Title V permits for major sources of any pollutant EPA determines to be "subject to regulation." The Department will work diligently with the stateAttorney General and the Secretaryof State so that the revisions will be in effect by January 2,2011 The proposed revisions to our regulations include all applicable revisions included in the federal rulemaking for both the PSD (40 CFR 5 1.1 66) and Title V (40 CFR part 70) regulations. For Title V, the Department has proposed to add the term "subject to regulation" to the definition of "major source" and to add the definition of "subject to regulation" to our regulations. For NSR, the Department has proposed to add the term "subject to regulation," to revise the language found at 40 CFR 5 1.166 (b)(49)(iv)to reflect the changes in the final rule, and to add the new language found at 40 CFR 5 1.166 (b)(49)(v)to our regulations. Please feel £reeto contact Lacey Hardin ofmy staff or me at (615) 532-0554 if you have any questions. Sincerely,

# R+

, Stephens,P.E., Director

Copy to: TennesseeAir Pollution Control Board Rob Raney, MetropolitanNashville Health Department Robert H. Colby, ChattanoogaIHarniltonCountyAir Pollution Control Bureau Lynne A. Liddington, Knoxville Dept. of Air QualityManagement Robert Rogers,MemphisIShelby County Health Department Green file
<PAGE>

                                                                  EXHIBIT 32 (b)

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection  with the Quarterly  Report of Northland  Cable  Properties  Seven
Limited  Partnership  (the  "Partnership")  on Form  10Q for  the  period  ended
September 30, 2005 as filed with the Securities  and Exchange  Commission on the
date  hereof  (the  "Form  10-Q"),   I,  Gary  Jones,   President  of  Northland
Communications Corporation,  the General Partner, certify, pursuant to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that;

     (1)  The Form 10-Q fully complies with the  requirements  of Section 13 (a)
          or (15(d) of the  Securities  Exchange  Act of 1934 (15 U.S.C.  78m or
          78(d)); and

     (2)  The  information  contained  in the Form 10-Q  fairly  presents in all
          material respects,  the financial  condition and results of operations
          of the Partnership.

DATE: 11-14-05

/s/ GARY S. JONES
    -------------
    Gary S. Jones
    President

A signed  original of this  written  statement  required by Section 906 has been
provided to Northland  Cable  Properties  Seven Limited  Partnership and will be
retained by Northland Cable Properties  Seven Limited  Partnership and furnished
to the Securities and Exchange Commission or its staff upon request.
§ 1.1370 What must be included in a petition requesting modified requirements or an exemption from the requirements? In addition to meeting the requirements on the content and format of a citizen petition in § 10.30 of this chapter, a petition requesting modified requirements or an exemption from the requirements of this subpart must: ( a ) Specify the food or type of entity to which the modified requirements or exemption would apply;
( b ) If the petition requests modified requirements, specify the proposed modifications to the requirements of this subpart; and
( c ) Present information demonstrating why application of the requirements requested to be modified or from which exemption is requested is not necessary to protect the public health.
§ 1316.66 Exceptions. ( a ) Within twenty days after the date upon which a party is served a copy of the report of the presiding officer, such party may file with the Hearing Clerk, Office of the Administrative Law Judge, exceptions to the recommended decision, findings of fact and conclusions of law contained in the report. The party shall include a statement of supporting reasons for such exceptions, together with evidence of record (including specific and complete citations of the pages of the transcript and exhibits) and citations of the authorities relied upon.
( b ) The Hearing Clerk shall cause such filings to become part of the record of the proceeding.
( c ) The Administrative Law Judge may, upon the request of any party to a proceeding, grant time beyond the twenty days provided in paragraph (a) of this section for the filing of a response to the exceptions filed by another party if he determines that no party in the hearing will be unduly prejudiced and that the ends of justice will be served thereby. Provided however, that each party shall be entitled to only one filing under this section; that is, either a set of exceptions or a response thereto.
[44 FR 55332, Sept. 26, 1979]
# L_2019120EN.01000301.xml

| 8.5.2019 | EN | Official Journal of the European Union | L 120/3 |
| --- | --- | --- | --- |

8.5.2019

EN

Official Journal of the European Union

L 120/3

---

COUNCIL DECISION (EU) 2019/703

of 8 October 2014

on the signing, on behalf of the Union and its Member States, of a Protocol amending the Agreement on Air Transport between Canada and the European Community and its Member States, to take account of the accession to the European Union of the Republic of Croatia

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 100(2), in conjunction with Article 218(5) thereof,

Having regard to the Act of Accession of Croatia, and in particular the second subparagraph of Article 6(2) thereof,

Having regard to the proposal from the European Commission,

Whereas:

| (1) | On 14 September 2012, the Council authorised the Commission to open negotiations, on behalf of the Union, its Member States and the Republic of Croatia, to conclude a Protocol amending the Agreement on Air Transport between Canada and the European Community and its Member States (1), to take account of the accession to the European Union of the Republic of Croatia (‘the Protocol’). |
| --- | --- |

(1)

On 14 September 2012, the Council authorised the Commission to open negotiations, on behalf of the Union, its Member States and the Republic of Croatia, to conclude a Protocol amending the Agreement on Air Transport between Canada and the European Community and its Member States (1), to take account of the accession to the European Union of the Republic of Croatia (‘the Protocol’).

| (2) | Those negotiations were successfully completed on 16 October 2013. |
| --- | --- |

(2)

Those negotiations were successfully completed on 16 October 2013.

| (3) | The Protocol should be signed on behalf of the Union and its Member States, subject to its conclusion at a later date, |
| --- | --- |

(3)

The Protocol should be signed on behalf of the Union and its Member States, subject to its conclusion at a later date,

HAS ADOPTED THIS DECISION:

Article 1

The signing of the Protocol amending the Agreement on Air Transport between Canada and the European Community and its Member States, to take account of the accession to the European Union of the Republic of Croatia (2) is hereby authorised on behalf of the Union and its Member States, subject to the conclusion of the Protocol.

Article 2

The President of the Council is hereby authorised to designate the person(s) empowered to sign the Protocol on behalf of the Union and its Member States.

Article 3

This Decision shall enter into force on the date of its adoption.

Done at Luxembourg, 8 October 2014.

For the Council

The President

M. LUPI

---

(1)  The text of the Agreement is published in OJ L 207, 6.8.2010, p. 32.

1

(2)  The text of the Protocol will be published together with the decision on its conclusion.

2

---
<PAGE>   1
                                                                    EXHIBIT 23.1


                             CONSENT OF INDEPENDENT
                          CERTIFIED PUBLIC ACCOUNTANTS

The Board of Directors
Spacelabs Medical, Inc.:

We consent to incorporation by reference in the registration statements (Nos.
33-47480, 33-50296, 33-71444, 33-95342 and 333-15815) on Form S-8 of Spacelabs
Medical, Inc., of our report dated January 30, 1998, relating to the
consolidated balance sheets of Spacelabs Medical, Inc. and subsidiaries as of
December 26, 1997 and December 27, 1996, and the related consolidated
statements of operations, shareholders' equity and cash flows and related
financial statement schedule for each of the years in the three-year period
ended December 26, 1997, which report appears in the December 26, 1997 annual
report on Form 10-K of Spacelabs Medical, Inc.



                                KPMG Peat Marwick LLP


Seattle, Washington
March 24, 1998
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Swift Energy
Pension  Partners  1992-B,  Ltd.'s  balance  sheet and  statement of  operations
contained in its Form 10-K for the year ended December 31, 1998 and is qualified
in its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-END>                                   DEC-31-1998
<CASH>                                         119,051
<SECURITIES>                                   0
<RECEIVABLES>                                  94,949
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               304,581
<PP&E>                                         5,316,058
<DEPRECIATION>                                 (4,464,902)
<TOTAL-ASSETS>                                 1,155,737
<CURRENT-LIABILITIES>                          11,789
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     1,143,948
<TOTAL-LIABILITY-AND-EQUITY>                   1,155,737
<SALES>                                        275,815
<TOTAL-REVENUES>                               284,694
<CGS>                                          0
<TOTAL-COSTS>                                  178,525<F1>
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                9,071
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            9,071
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   9,071
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1>Includes  lease  operating  expenses,  production  taxes  and  depreciation,
depletion and  amortization  expense.  Excludes general and  administrative  and
interest expense.
</FN>
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                          11,693
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                46,800
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     17,156
<INVESTMENTS-CARRYING>                          19,182
<INVESTMENTS-MARKET>                            19,729
<LOANS>                                        190,257
<ALLOWANCE>                                      4,068
<TOTAL-ASSETS>                                 302,001
<DEPOSITS>                                     265,591
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              2,102
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        18,483
<OTHER-SE>                                      15,824
<TOTAL-LIABILITIES-AND-EQUITY>                 302,001
<INTEREST-LOAN>                                 10,024
<INTEREST-INVEST>                                2,129
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                12,153
<INTEREST-DEPOSIT>                               3,992
<INTEREST-EXPENSE>                                   5
<INTEREST-INCOME-NET>                            8,157
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  5,173
<INCOME-PRETAX>                                  3,975
<INCOME-PRE-EXTRAORDINARY>                       3,975
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,490
<EPS-PRIMARY>                                      .30
<EPS-DILUTED>                                      .30
<YIELD-ACTUAL>                                    .884
<LOANS-NON>                                        428
<LOANS-PAST>                                       156
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 1,780
<CHARGE-OFFS>                                       60
<RECOVERIES>                                        15
<ALLOWANCE-CLOSE>                                3,633
<ALLOWANCE-DOMESTIC>                             3,673
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
```

Exhibit 21

                                                     SUBSIDIARIES
                                                     ------------

Domestic Subsidiaries of the Company:
-------------------------------------

   Name of Subsidiary                                State of Incorporation
   ------------------                                ----------------------

   PCT International Holdings, Inc.                  Delaware

   Flavors Holdings, Inc.                            Delaware

   Mafco Worldwide Corporation                       Delaware

   Mafco Shanghai Corporation                        Delaware

   EVD Holdings Inc.                                 Delaware

   Pneumo Abex, LLC                                  Delaware

   Jensen Kelly Corporation                          Delaware

   Concord Pacific Corporation (50% owned)           Maine

   Pneumo Abex Lessee Corp.                          Delaware

Foreign Subsidiaries of the Company:
------------------------------------

   Name of Subsidiary                                Jurisdiction
   ------------------                                ------------

   EVD Holdings S.A.S.                               France

   Extraits Vegetaux Et Derives, S.A.S.              France

   Wei Feng Enterprises Ltd. (50% owned)             British Virgin Islands

   Xianyang Concord Natural Products Co. Ltd.
      (50% owned)                                    Peoples Republic of China

   Zhangjiagang Free Trade Zone MAFCO Liantai
      Biotech Co., Ltd. (50% owned)                  Peoples Republic of China

   Mafco Weihai Green Industry of Science and
     Technology Co. Ltd. (40% owned)                 Peoples Republic of China
```
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA F OURTH D ISTRICT

JOSE JORGE GARCIA , Appellant,

v.

STATE OF FLORIDA , Appellee

.

No. 4D 17

- 1368

[ November 30 , 2017 ]

Appeal of order denying rule 3.850 motion from the Circuit Court for the Fifteenth Judicial Circuit, Palm Beach County ; Samantha Schosberg Feuer , Judge; L.T. Case No. 50

- 2010

- CF

- 009508

- AXXX

- MB

.
Jose Jorge Garcia

, Madison, pro se.

No appearance required for appellee.

P ER C URIAM

.
Affirmed

.

G ROSS , C IKLIN and L EVINE , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
§ 310.534 Drug products containing active ingredients offered over-the-counter (OTC) for human use as oral wound healing agents. ( a ) Allantoin, carbamide peroxide in anhydrous glycerin, water soluble chlorophyllins, and hydrogen peroxide in aqueous solution have been present in oral mucosal injury drug products for use as oral wound healing agents. Oral wound healing agents have been marketed as aids in the healing of minor oral wounds by means other than cleansing and irrigating, or by serving as a protectant. Allantoin, carbamide peroxide in anhydrous glycerin, water soluble chlorophyllins, and hydrogen peroxide in aqueous solution are safe for use as oral wound healing agents, but there are inadequate data to establish general recognition of the effectiveness of these ingredients as oral wound healing agents.
( b ) Any OTC drug product that is labeled, represented, or promoted for use as an oral wound healing agent is regarded as a new drug within the meaning of section 201(p) of the Federal Food, Drug, and Cosmetic Act, for which an approved new drug application under section 505 of the act and part 314 of this chapter is required for marketing. In the absence of an approved new drug application, such product is also misbranded under section 502 of the act.
( c ) Clinical investigations designed to obtain evidence that any drug product labeled, represented, or promoted for OTC use as an oral wound healing agent is safe and effective for the purpose intended must comply with the requirements and procedures governing the use of investigational new drugs set forth in part 312 of this chapter.
( d ) After the effective date of the final regulation, any OTC drug product that is labeled, represented, or promoted for use as an oral wound healing agent may not be initially introduced or initially delivered for introduction into interstate commerce unless it is the subject of an approved new drug application.
[51 FR 26114, July 18, 1986, as amended at 55 FR 11579, Mar. 29, 1990]
<PAGE>
MEDIALINK WORLDWIDE INCORPORATED AND SUBSIDIARIES

Exhibit 99.1

                            Certification Pursuant to
                             18 U.S.C. Section 1350,
      as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


            Pursuant to 18 U.S.C.  ss. 1350, as adopted  pursuant to Section 906
of  the  Sarbanes-Oxley  Act of  2002,  the  undersigned  officer  of  Medialink
Worldwide  Incorporated  (the  "Company"),  hereby  certifies to such  officer's
knowledge,  that the  Company's  Quarterly  Report on Form 10-Q for the  quarter
ended March 31, 2003 (the  "Report")  fully  complies with the  requirements  of
Section 13(a) or 15(d),  as applicable,  of the Securities  Exchange Act of 1934
and that  the  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


Dated: May 14, 2003


                                             /s/ Laurence Moskowitz_
                                             ----------------------
                                             Name:  Laurence Moskowitz
                                             Title: Chief Executive Officer


The foregoing  certification is being furnished solely pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.



<PAGE>